Fennec Pharmaceuticals (FENC) Earnings Date, Estimates & Call Transcripts → Warren Buffett's 'mystery stock' (From Stansberry Research) (Ad) Free fenc Stock Alerts $7.31 +0.27 (+3.84%) (As of 04:00 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateAug. 1EstimatedActual EPS (May. 14) $0.41 Missed By -$0.08 Consensus EPS (May. 14) $0.49 Read Call TranscriptListen to Call Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueFENC Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.FENC Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry Fennec Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20242($0.05)($0.02)($0.04) Q2 20243($0.14)$0.42$0.07 Q3 20243($0.10)$0.24$0.05 Q4 20243($0.07)$0.42$0.13 FY 202411($0.36)$1.06$0.22 Q1 20253$0.05$0.09$0.07 Q2 20253$0.09$0.55$0.28 Q3 20253$0.12$1.27$0.55 Q4 20253$0.13$2.56$1.01 FY 202512$0.39$4.47 $1.91FENC Earnings Date and InformationFennec Pharmaceuticals last announced its earnings results on May 14th, 2024. The reported $0.41 earnings per share for the quarter, missing the consensus estimate of $0.49 by $0.08. The company earned $25.38 million during the quarter, compared to analysts' expectations of $10.46 million. Fennec Pharmaceuticals has generated $0.03 earnings per share over the last year ($0.03 diluted earnings per share) and currently has a price-to-earnings ratio of 242.0. Earnings for Fennec Pharmaceuticals are expected to grow by 300.00% in the coming year, from $0.39 to $1.56 per share. Fennec Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off prior year's report dates.Read More Fennec Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/1/2024Estimated)------- 5/14/2024Q1 2024$0.49$0.41($0.08)$0.41$10.46 million$25.38 million 3/21/2024Q4 2023$0.02($0.10)($0.12)($0.10)$9.47 million$9.74 million11/6/2023Q3 2023($0.11)($0.07)+$0.04($0.07)$5.22 million$6.52 million 8/3/2023Q2 2023($0.18)($0.21)($0.03)($0.21)$4.01 million$3.33 million5/11/2023Q1 2023($0.21)($0.23)($0.02)($0.23)$1.88 million$1.68 million3/30/2023Q4 2022($0.24)($0.26)($0.02)($0.26)$1.97 million-This Apple-like Innovator is Revolutionizing Healthcare (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry11/11/2022Q3 2022($0.17)($0.31)($0.14)($0.31)--8/12/2022Q2 2022($0.10)($0.19)($0.09)($0.19)--5/12/2022Q1 2022($0.13)($0.14)($0.01)($0.14)-- 2/28/2022Q4 2021$3.52($0.18)($3.70)($0.18)--11/10/2021Q3 2021($0.17)($0.16)+$0.01($0.16)--8/10/2021Q2 2021($0.19)($0.15)+$0.04($0.15)-- Fennec Pharmaceuticals Earnings - Frequently Asked Questions When is Fennec Pharmaceuticals's earnings date? Fennec Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off last year's report dates. Learn more on FENC's earnings history. Did Fennec Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Fennec Pharmaceuticals (NASDAQ:FENC) missed the analysts' consensus estimate of $0.49 by $0.08 with a reported earnings per share (EPS) of $0.41. Learn more on analysts' earnings estimate vs. FENC's actual earnings. How can I listen to Fennec Pharmaceuticals's earnings conference call? The conference call for Fennec Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Fennec Pharmaceuticals's conference call transcript? The conference call transcript for Fennec Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Fennec Pharmaceuticals generate each year? Fennec Pharmaceuticals (NASDAQ:FENC) has a recorded annual revenue of $21.25 million. How much profit does Fennec Pharmaceuticals generate each year? Fennec Pharmaceuticals (NASDAQ:FENC) has a recorded net income of -$16.05 million. FENC has generated $0.03 earnings per share over the last four quarters. What is Fennec Pharmaceuticals's price-to-earnings ratio? Fennec Pharmaceuticals (NASDAQ:FENC) has a trailing price-to-earnings ratio of 242.00 and a forward price-to-earnings ratio of 18.62. What is Fennec Pharmaceuticals's EPS forecast for next year? Fennec Pharmaceuticals's earnings are expected to grow from $0.39 per share to $1.56 per share in the next year, which is a 300.00% increase. More Earnings Resources from MarketBeat Related Companies: Kodiak Sciences Earnings Date Century Therapeutics Earnings Date Elevation Oncology Earnings Date INmune Bio Earnings Date Adverum Biotechnologies Earnings Date Compugen Earnings Date Acumen Pharmaceuticals Earnings Date Compass Therapeutics Earnings Date Zura Bio Earnings Date Agenus Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Baidu Stock Earnings Prove Ray Dalio Right about China?JD’s Earnings Could Mean Chinese Stocks Making a ComebackHome Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-Turn This page (NASDAQ:FENC) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDoes this make you sick?Allegiance GoldThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge Alerts Adding Choose a watchlist: Watchlist My Default Watchlist Adding Fennec Pharmaceuticals Inc You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
